EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 11

Ensembl ID : ENSOSIG00000013833
Gene Symbol: PSMD11
1 Cross references
207 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 12

Ensembl ID : ENSOSIG00000017489
Gene Symbol: PSMD12
1 Cross references
220 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 13

Ensembl ID : ENSOSIG00000006590
Gene Symbol: PSMD13
1 Cross references
216 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 14

Ensembl ID : ENSOSIG00000014589
Gene Symbol: PSMD14
1 Cross references
214 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 6

Ensembl ID : ENSOSIG00000021116
Gene Symbol: PSMD6
1 Cross references
212 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 7

Ensembl ID : ENSOSIG00000007069
Gene Symbol: PSMD7
1 Cross references
235 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSOSIG00000013140
Gene Symbol: PSMB11
1 Cross references
169 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSOSIG00000013241
Gene Symbol: PRMT5
1 Cross references
198 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSOSIG00000013150
Gene Symbol: PRKCB
1 Cross references
207 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSOSIG00000012138
Gene Symbol: PRKCD
1 Cross references
134 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSOSIG00000020168
Gene Symbol: PRKCD
1 Cross references
203 Possible Orthologues:

Protein Kinase C, Alpha, A

Ensembl ID : ENSOSIG00000018458
Gene Symbol: PRKCAA
1 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).